USA Financial Formulas’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$136K Buy
1,346
+656
+95% +$75.1K 0.03% 163
2026
Q2
$81.6K Buy
+690
New +$79.6K 0.01% 207
2024
Q3
– Sell
-5,895
Closed -$800K – 375
2024
Q2
$800K Buy
+5,895
New +$802K 0.13% 85
2022
Q3
– Sell
-15
Closed -$1K – 433
2022
Q2
$1K Hold
15
– – ﹤0.01% 314
2022
Q1
$1K Hold
15
– – ﹤0.01% 340
2021
Q4
$2K Sell
15
-7
-32% -$869 ﹤0.01% 280
2021
Q3
$3K Buy
22
+7
+47% +$901 ﹤0.01% 302
2021
Q2
$2K Buy
15
+1
+7% +$114 ﹤0.01% 330
2021
Q1
$1K Sell
14
-3
-18% -$304 ﹤0.01% 325
2020
Q4
$2K Sell
17
-21
-55% -$1.97K ﹤0.01% 244
2020
Q3
$3K Hold
38
– – ﹤0.01% 205
2020
Q2
$2K Buy
+38
New +$2.51K ﹤0.01% 134
2018
Q3
– Sell
-49,747
Closed -$3.83M – 418
2018
Q2
$3.83M Sell
49,747
-392
-0.8% -$28.5K 0.93% 32
2018
Q1
$3.86M Sell
50,139
-5,046
-9% -$373K 0.93% 32
2017
Q4
$3.76M Buy
+55,185
New +$3.66M 0.9% 46
2017
Q1
– Sell
-52,308
Closed -$2.59M – 353
2016
Q4
$2.59M Sell
52,308
-10,027
-16% -$508K 0.64% 55
2016
Q3
$3.27M Buy
+62,335
New +$3.06M 0.84% 26

Other funds holding XYL

USA Financial Formulas's XYL Position: Q3 2026 in Review

USA Financial Formulas increased its Xylem (XYL) stake by 95% in Q3 2026, buying an estimated $75.1K and bringing the position to 1,346 shares worth $136K. The position accounts for 0.03% of the portfolio, ranked #163.

USA Financial Formulas first reported a position in XYL in Q3 2016 and has held it in 17 quarters since. The position peaked at $3.86M in Q1 2018. 773 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • USA Financial Formulas held 1,346 shares of Xylem worth $136K as of Q3 2026.
  • USA Financial Formulas bought 656 Xylem shares in Q3 2026, an estimated $75.1K.
  • Xylem made up 0.03% of USA Financial Formulas's portfolio in Q3 2026, its #163 holding.
  • USA Financial Formulas first reported a position in Xylem in Q3 2016 and has held it in 17 quarters since.
  • USA Financial Formulas's Xylem position peaked at $3.86M in Q1 2018.
  • 773 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.